MEDLINE INC

Historical 13F Holders

Symbol
MDLN
CUSIP
58507V107
All holders as of
Q2 2026
Type
Equity
Class
COM CL A
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 58507V107 since 12/18/2024, newest first.

Filer % of Class Filed
Hellman & Friedman Capital Partners X (Parallel), L.P. 13G/A Amendment 2
16.0% 8/11/2026
Event 6/30/2026
Blackstone Holdings II L.P. 13G/A Amendment 2
16.5% 8/7/2026
Event 6/30/2026
FMR LLC 13G
5.5% 8/6/2026
Event 6/30/2026
Carlyle Group Inc. 13G/A Amendment 1
20.6% 5/15/2026
Event 3/31/2026
Abu Dhabi Investment Authority 13G/A Amendment 1
4.9% 5/7/2026
Event 3/31/2026
Hellman & Friedman Capital Partners X (Parallel), L.P. 13G/A Amendment 1
19.8% 5/6/2026
Event 3/31/2026
Blackstone Holdings II L.P. 13G/A Amendment 1
20.6% 5/1/2026
Event 3/31/2026
Carlyle Group Inc. 13G
24.4% 2/13/2026
Event 12/31/2025
Hellman & Friedman Capital Partners X (Parallel), L.P. 13G
23.2% 2/13/2026
Event 12/31/2025
Blackstone Holdings II L.P. 13G
24.4% 2/13/2026
Event 12/31/2025
Mozart Holdco, Inc. 13G 22.4% 2/13/2026
Event 12/31/2025
Abu Dhabi Investment Authority 13G
5.9% 2/11/2026
Event 12/31/2025
GIC Private Ltd 13G
14.6% 12/29/2025
Event 12/18/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 53 24.4 M $848 M
2026 Q2 431 876 M $34.3 B
2026 Q1 333 761 M $33.8 B
2025 Q4 214 718 M $30.2 B